nafamostat has been researched along with angiotensin ii in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, K; Ideishi, M; Ikeda, M; Noda, K; Sasaguri, M | 2 |
| Arakawa, K; Ideishi, M; Kinoshita, A; Miura, S; Motoyama, M; Sakai, T; Sasaguri, M; Shindo, M; Tanaka, H | 1 |
1 trial(s) available for nafamostat and angiotensin ii
| Article | Year |
|---|---|
Angiotensin II formation by an alternative pathway during exercise in humans.
Topics: Adult; Angiotensin I; Angiotensin II; Benzamidines; Blood Pressure; Bradykinin; Captopril; Cross-Over Studies; Double-Blind Method; Exercise; Guanidines; Heart Rate; Humans; Lactates; Lactic Acid; Male; Peptidyl-Dipeptidase A; Renin; Serine Proteinase Inhibitors | 1994 |
2 other study(ies) available for nafamostat and angiotensin ii
| Article | Year |
|---|---|
Cardioprotection of ACE inhibitor in ischemic heart is not dependent on the local angiotensin II formation.
Topics: Angiotensin II; Animals; Benzamidines; Blood Pressure; Bradykinin; Captopril; Cardiac Output; Coronary Circulation; Coronary Vessels; Dogs; Guanidines; Heart; Hemodynamics; Kallikreins; Male; Myocardial Infarction; Myocardium; Vascular Resistance | 1992 |
Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs.
Topics: Angiotensin II; Animals; Benzamidines; Bradykinin; Captopril; Dogs; Guanidines; Hemodynamics; Male; Myocardial Infarction; Oligopeptides; Serine Proteinase Inhibitors | 1993 |